IMATIFLOW 400 MG Imatinib IP (400mg) Imatinib is a medication used in the treatment of certain types of cancer, particularly chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). It is a tyrosine kinase inhibitor that specifically targets and inhibits the activity of proteins associated with cancer cell growth and division. The "IP" in "IMATIFLOW 400 MG" is not a standard abbreviation or designation for this medication. Imatinib is typically referred to by its generic name "Imatinib" or by its brand name "Gleevec" (or "Glivec" in some regions). The standard recommended dose of IMATIFLOW 400 MG for adults with chronic myeloid leukemia (CML) is usually 400 milligrams (mg) taken orally once daily. For gastrointestinal stromal tumors (GISTs), the dosage may vary based on the specific situation and the recommendations of the healthcare provider. Imatinib works by inhibiting the activity of specific tyrosine kinases, such as BCR-ABL in CML and KIT in GISTs, which are responsible for the uncontrolled growth and division of cancer cells. By blocking these proteins, imatinib can help slow down or inhibit the progression of cancer and improve patient outcomes. Common side effects of imatinib may include nausea, vomiting, diarrhea, fatigue, and fluid retention, among others. More severe side effects can occur, so it's important for patients to report any unusual or severe symptoms to their healthcare provider. Patients prescribed imatinib should follow their healthcare provider's instructions carefully, take the medication as prescribed, and attend regular follow-up appointments for monitoring and potential adjustments to their treatment plan. Effective communication with the healthcare team is essential to ensure the best possible outcome for patients with CML or GISTs treated with imatinib. Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us. For further information please contact: info@sterispharma.com order now: https://www.sterisonline.com/product/imatiflow-400-133660